EDGE
Get a demo
Log In
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries

Gracell Biotechnologies

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. The company's therapy offers cellular therapeutics for the patients suffered from hematological malignancy, solid tumor or degenerative disease, enabling healthcare providers to cure their patients and improve their lives.

Company Brief

HQ location:
Suzhou
Founded year:
2017
Employees:
251 - 500
Website:
Total Funding:
USD 285.0 million

Funding

Investors

No investor data is available

Funding data are powered by Crunchbase
About EDGE
Contact Us
Resources
SPEEDA EDGE logo

Technology Research Made Effortless

Get a demo
Terms & conditionsPrivacy policyDo not sell my personal information
SPEEDA Edge is owned by Uzabase, the business intelligence and media company. © 2024 Uzabase, Inc. and Uzabase USA, Inc. All rights reserved.
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.